Portola Pharmaceuticals Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Portola Pharmaceuticals Inc PTLA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 18.03 20:00:00
Close Price Low Price High Price Open Price Previous Close
18.03 18.03
Bid Price Ask Price Spread News
18.00 18.10 0.10 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 18.03 USD

Portola Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.42B 78.48M 77.92M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Portola Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PTLA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months7.2918.196.6417.315,058,82410.74147.33%
1 Year28.4531.415.3116.162,449,633-10.42-36.63%
3 Years50.6556.6965.3125.461,545,638-32.62-64.4%
5 Years46.9467.105.3128.131,272,852-28.91-61.59%

Portola Pharmaceuticals Description

Portola Pharmaceuticals Inc is a biotechnology company focused on developing and commercializing novel therapeutics. The company focuses on areas of thrombosis, other hematologic disorders, and inflammation for patients who have limited or no approved treatment options. Portola focuses on biomarker or genetic approaches to clinical development that it believes will increase the probability of clinical, regulatory, and commercial success of first-in-class therapies. The company also uses collaborative agreements.

Your Recent History
Portola Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.